Vivos Therapeutics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+64.6% +$10M
$25M
Current Assets↓-41.3% -$3M
$4M
Cash & Equivalents↓-67.6% -$4M
$2M
Receivables↑+267.7% +$1M
$2M
Net PPE↑+13.5% +$446K
$4M
Goodwill↑+201.5% +$6M
$9M
Intangibles↑+889.0% +$4M
$4M
Total Liabilities↑+264.3% +$19M
$27M
Current Liabilities↑+263.1% +$13M
$18M
Account Payables↑+52.9% +$581K
$2M
Long-Term Debt
$753K
Stockholders Equity↓-118.7% -$9M
$-1M
Retained Earnings↓-20.3% -$21M
$-125M
Operating Lease ROU Asset↑+303.7% +$3M
$4M
Operating Lease Liability↑+335.9% +$3M
$5M
Gross PP&E↑+9.9% +$602K
$7M
Accumulated Depreciation↑+5.6% +$156K
$3M
Debt Due Y1
$284K
Debt Due Y2
$211K
Debt Due Y3
$162K
Debt Due Y4
$49K
Debt Due Y5
$31K
Debt Due >Y5
$16K
Total Debt Carrying Amount↓-37.3% -$447K
$753K
Contract Liability↓-51.8% -$514K
$479K
Contract Liability (Current)↓-46.5% -$417K
$479K
Contract Liability (Noncurrent)↓-99.4% -$177K
$1K